Researchers based in Gabon and France report the discovery of a new malaria agent infecting chimpanzees in Central Africa. This new species, named Plasmodium gaboni, is a close relative of the most virulent human agent P. falciparum; it is described in an article published May 29 in the open-access journal...
Latest News
SCOTTSDALE, Ariz. — MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report entitled “Thought Leader Insight & Analysis: Alzheimer’s Disease,” designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments...
Using a new technology for inserting large DNA sections into a genome, scientists have successfully created a mouse model of Parkinson’s disease that has the same impairments of movement and degenerative brain changes as the human disease, according to a study published online June 7 in Nature Neuroscience. Yanping Li,...
MIAMI, FLORIDA – A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. The study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the first to quantify tumor...
BUFFALO, NY – A new research paper was published in Oncotarget’s Volume 15 on August 14, 2024, entitled, “A nanobody against the V-ATPase c subunit inhibits metastasis of 4T1-12B breast tumor cells to lung in mice.” The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that functions to control the...
Sydney, Australia – An international research team has discovered a new way to effectively treat cancer, by using nutrients to reactivate suppressed metabolic pathways in cancer cells. The researchers used a common amino acid, tyrosine, packaged as a nanomedicine, to change the metabolism of melanoma, a deadly skin cancer, and...
Seoul, South Korea – A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new...
Seattle, WA – More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a July 25 JAMA Oncology review article by experts at Fred Hutch Cancer Center and University...
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) today announced publication of new NCCN Guidelines for Patients®: Small Bowel Adenocarcinoma. This free resource for people facing cancer and caregivers is focused on a rare cancer type that typically occurs in the small intestine, where routine screening is impossible,...
To accelerate the development of gene therapies for the 30 million Americans who have been diagnosed with a rare disease, in October 2021 the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), 10 pharmaceutical companies, and five nonprofit organizations announced the creation of the Bespoke Gene Therapy Consortium (BGTC)....